Texas House Bill HB4673

Texas 2025 - 89th Regular

• Filed: 3/12/25

Caption

Relating to the effect of certain reductions in a health benefit plan enrollee's out-of-pocket expenses for prescription drugs that are essential health benefits on the enrollee's cost-sharing requirements.

Impact

If enacted, HB 4673 will have significant implications for how health benefit plans are administered in Texas. It will require that any decrease in out-of-pocket costs for essential prescription drugs must be considered in the overall cost-sharing structure of health plans. The bill aims to enhance transparency and ensure that enrollees benefit directly from any reductions, potentially lowering their financial burdens when accessing necessary medications.

Summary

House Bill 4673 aims to modify the Texas Insurance Code regarding the management of out-of-pocket expenses for prescription drugs classified as essential health benefits. This bill specifically addresses how reductions in these out-of-pocket expenses should be reflected in an enrollee's cost-sharing obligations under their health benefit plans. The bill provides a framework for health plan issuers, pharmacy benefit managers, and their subcontractors to apply cost reductions appropriately to deductibles and copayments for qualifying drugs.

Contention

While the bill is primarily oriented towards reducing financial strain on patients, its passage may encounter some opposition. Concerns may arise from health insurers regarding the operational changes required to adhere to the new regulations, particularly relating to the definition and management of essential health benefits. Stakeholders could debate the feasibility of implementing these changes and the impacts on insurance premiums and coverage options for enrollees.